Drug Database
Back to search

Finland· FI-REL-REL9191

Quadramet

A samarium (153sm) lexidronam product containing samarium (153 sm) lexidronam, registered in Finland by CIS bio international. The same ATC class is registered in 8 of our 19 countries.

ATC V10BX02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedQuadrametATCV10BX02REGISTER NO.FI-REL-REL9191PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about samarium (153 sm) lexidronamAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Samarium (153sm) lexidronam is registered in 8 of 19 countries.

Countries holding a registration under ATC V10BX02 (samarium (153sm) lexidronam), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 5 of them publish a price we can compare per daily dose
Search samarium (153sm) lexidronam products by name

Samarium (153sm) lexidronam · ATC V10BX02

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Samarium (153 Sm) lexidronam
Manufacturer
CIS bio international
Country
Finland (FI)
ATC code
V10BX02
ATC class
Samarium (153Sm) lexidronam
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V10BX02

Samarium (153sm) lexidronam, as other registers publish it.

All samarium (153sm) lexidronam products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5315cfd2-5404-446b-a92d-b5a3efe28f2c
GET /v1/drugs/5315cfd2-5404-446b-a92d-b5a3efe28f2c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos",
  "route": "Laskimoon",
  "ddd_unit": null,
  "strength": "1.3 GBq/ml",
  "atc_label": "samarium(153Sm)leksidronaami",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/97/057/001",
  "fimea_rel_id": "REL9191",
  "authorised_at": "1998-02-05"
}
API referenceMCP serverPlans

See everything about samarium (153sm) lexidronam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console